PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system<b>?</b>
Cristina Raimondi(Sapienza University of Rome), Paola Gazzaniga(Sapienza University of Rome)
Cited by 78
Related Papers
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
CD69 is expressed on platelets and mediates platelet activation and aggregation.
|The Journal of Experimental Medicine|1990|104
Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4–Mediated Transport
|Journal of the American College of Cardiology|2011|86